Principal Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.47M | Sell |
|
|||||
|
2025
Q2 | $16.5M | Buy |
|
|||||
|
2025
Q1 | $9.37M | Buy |
|
|||||
|
2024
Q4 | $2.44M | Sell |
|
|||||
|
2024
Q3 | $2.92M | Sell |
|
|||||
|
2024
Q2 | $3.45M | Sell |
|
|||||
|
2024
Q1 | $2.89M | Sell |
|
|||||
|
2023
Q4 | $3.76M | Sell |
|
|||||
|
2023
Q3 | $3.99M | Buy |
|
|||||
|
2023
Q2 | $4.11M | Buy |
|
|||||
|
2023
Q1 | $4.2M | Sell |
|
|||||
|
2022
Q4 | $5.69M | Sell |
|
|||||
|
2022
Q3 | $5.29M | Sell |
|
|||||
|
2022
Q2 | $4.6M | Buy |
|
|||||
|
2022
Q1 | $4.65M | Sell |
|
|||||
|
2021
Q4 | $5.09M | Sell |
|
|||||
|
2021
Q3 | $7.3M | Sell |
|
|||||
|
2021
Q2 | $7.28M | Buy |
|
|||||
|
2021
Q1 | $5.66M | Buy |
|
|||||
|
2020
Q4 | $4.95M | Buy |
|
|||||
|
2020
Q3 | $4.83M | Sell |
|
|||||
|
2020
Q2 | $5.36M | Buy |
|
|||||
|
2020
Q1 | $3.15M | Buy |
|
|||||
|
2019
Q4 | $3.16M | Sell |
|
|||||
|
2019
Q3 | $2.21M | Sell |
|
|||||
|
2019
Q2 | $2.07M | Buy |
|
|||||
|
2019
Q1 | $2.4M | Buy |
|
|||||
|
2018
Q4 | $1.74M | Sell |
|
|||||
|
2018
Q3 | $2.2M | Buy |
|
|||||
|
2018
Q2 | $2.39M | Sell |
|
|||||
|
2018
Q1 | $2.92M | Buy |
|
|||||
|
2017
Q4 | $2.96M | Buy |
|
|||||
|
2017
Q3 | $1.55M | Sell |
|
|||||
|
2017
Q2 | $1.22M | Buy |
|
|||||
|
2017
Q1 | $632K | Sell |
|
|||||
|
2016
Q4 | $481K | Sell |
|
|||||
|
2016
Q3 | $1.02M | Sell |
|
|||||
|
2016
Q2 | $841K | Buy |
|
|||||
|
2016
Q1 | $841K | Sell |
|
|||||
|
2015
Q4 | $1.27M | Buy |
|
|||||
|
2015
Q3 | $1.08M | Buy |
|
|||||
|
2015
Q2 | $893K | Buy |
|
|||||
|
2015
Q1 | $470K | Sell |
|
|||||
|
2014
Q4 | $506K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.93M | Sell |
|
|||||
|
2014
Q1 | $5.13M | Sell |
|
|||||
|
2013
Q4 | $4.93M | Buy |
|
|||||
|
2013
Q3 | $4.63M | Buy |
|
|||||
|
2013
Q2 | $527K | Buy |
|